4 company-specific changes
fiscal period 2025-12-31
filed 2026-01-29
- Reality Labs losses increased from $17.73B (2024) to $19.19B (2025); new disclosure of financing dependency and capital-raising risks for sustaining investments.
- New specific AI-related IP litigation risks disclosed: copyright claims for AI training data and outputs, statutory damages per-work basis creating potentially massive exposure, and trade secret misappropriation claims.
See the full detail →
11 company-specific changes
fiscal period 2025-12-31
filed 2026-01-29
- New specific disclosure of repealed/restricted tax credits and regulatory credit programs, plus OBBBA compliance requirements affecting battery costs and mineral traceability, escalating regulatory risk.
- New material business line (Robotaxi/autonomous ride-hailing) disclosed with explicit dependency on consumer adoption and competitive risks. Substantive expansion of business model and risk profile.
See the full detail →
2 company-specific changes
fiscal period 2025-12-31
filed 2026-01-29
- New disclosure of Executive Orders imposing acquisition transformation, multi-year contracts, and restrictions on dividends, repurchases, and executive compensation for defense contractors.
- International sales grew from 26% to 28% of total sales. New language adds "relations between U.S. Government and international customers" as a risk factor affecting FMS sales, escalating geopolitical exposure.
See the full detail →
4 company-specific changes
fiscal period 2025-12-31
filed 2026-01-28
- Removal of material debt servicing risk disclosure. Prior year flagged significant cash flow and debt repayment concerns; deletion suggests improved financial position or reduced leverage.
- New $5B repurchase program announced with $1.15B planned for 2026 materially impacts capital allocation, cash reserves, and financial flexibility for growth, dividends, and M&A.
See the full detail →
9 company-specific changes
fiscal period 2025-11-30
filed 2026-01-28
- Millrose spin-off completed as planned (distribution Feb 7, 2025). Removal of uncertainty risk regarding transaction completion and timing is material.
- New disclosure of material adverse effect risk from option forfeiture and impairments; expanded scope and explicit materiality language added.
See the full detail →
1 company-specific change
fiscal period 2025-11-30
filed 2026-01-27
- New material risk: proposed DLC unification and Bermuda redomiciliation introduces governance, regulatory approval, and shareholder approval uncertainties with potential adverse effects on share price and shareholder protections.
See the full detail →
9 company-specific changes
fiscal period 2025-12-31
filed 2026-01-27
- Customer concentration decreased (87% to 84%), but disclosure expanded significantly: added stop-work order risks, Nunn-McCurdy Act impacts, and new contract restrictions on capital deployment. Material escalation of government customer risk.
- New disclosure of executive order restricting share repurchases/dividends and addressing underperformance; expanded consequences including contract termination and payment withholds; increased regulatory uncertainty and enforcement risk.
See the full detail →
18 company-specific changes
fiscal period 2025-12-31
filed 2026-01-27
- New disclosure of $7.9B in EV-related charges due to slower-than-anticipated consumer adoption and policy changes. Material financial impact and strategic risk.
- Removal of material EV adoption risk disclosure signals company confidence in EV strategy execution and reduced concern about slower-than-anticipated consumer adoption impacting operations and financial results.
See the full detail →
6 company-specific changes
fiscal period 2025-12-31
filed 2026-01-26
- Company disclosed a 45% dividend cut ($0.60 reduction per share) in Q4 2025, a material adverse change affecting shareholder returns and signaling financial stress.
- Newly disclosed material risks: FDA/NIH/CDC workforce cuts, NIH budget cuts/freeze, drug pricing regulation, Medicaid cuts, tariffs, government shutdown. Directly threaten tenant operations, R&D funding, capital availability, and real estate demand.
See the full detail →
7 company-specific changes
fiscal period 2025-12-31
filed 2026-01-23
- New disclosure of major M&A transaction risk: $5.8B termination fee exposure, regulatory approval uncertainty, and potential material adverse effects on WBD business post-closing.
- New disclosure of material M&A integration risk. WBD transaction introduces substantive risks: synergy realization failure, operational disruption, management distraction, and unforeseen expenses—all material to financial results and investor decision-making.
See the full detail →
1 company-specific change
fiscal period 2025-12-31
filed 2026-01-23
- Removal of material acquisition risk. ChampionX deal completion uncertainty, regulatory approval risk, and termination fee liability no longer disclosed—indicates deal closed or abandoned.
See the full detail →
3 company-specific changes
fiscal period 2025-11-30
filed 2026-01-22
- Added soybean oil as significant raw material with active hedging derivatives; expanded mitigation to include "other streamlining initiatives"; added "global trade policies" as governmental risk factor.
- New specific regulatory risks disclosed: FDA phase-out of synthetic dyes and MAHA Commission recommendations on chronic disease. These represent concrete regulatory developments with potential business impact.
See the full detail →
1 company-specific change
fiscal period 2025-11-28
filed 2026-01-15
- Senior unsecured notes increased $500M (8.8%) from $5.65B to $6.15B, materially increasing debt burden and financial leverage.
See the full detail →
15 company-specific changes
fiscal period 2025-10-31
filed 2025-12-22
- Removal of Ansys Merger risk factors indicates deal completion or abandonment. Material change resolving significant M&A and debt-related uncertainties disclosed last year.
- Removal of material liquidity and debt risk tied to pending Ansys Merger. Merger likely did not close or was abandoned, eliminating disclosed financing and capital structure concerns.
See the full detail →
16 company-specific changes
fiscal period 2025-11-02
filed 2025-12-18
- New disclosure of material tariff impact: $600M incremental cost in FY2025, with ongoing exposure. Substantive operational and financial risk from trade policy escalation.
- Shift to Mexico now subject to actual 2025 tariffs with uncertain USMCA exemption. New water scarcity risk disclosed. Concrete cost impact materialized.
See the full detail →
17 company-specific changes
fiscal period 2025-10-31
filed 2025-12-18
- Merger with Juniper Networks completed; pending deal risk and $815M termination fee exposure eliminated. Material risk resolved.
- Added specific Juniper Networks merger integration risks, including ongoing management diversion, Tunney Act litigation disruption, and potential reputational/customer uncertainty—material new operational and legal complexities.
See the full detail →
17 company-specific changes
fiscal period 2025-11-02
filed 2025-12-18
- Removal of VMware integration risk indicates successful completion or resolution of major M&A integration challenges that previously posed material business and financial risk.
- Added explicit AI-driven industry transformation risk. Semiconductor industry now described as "undergoing profound change due to AI," escalating cyclicality risk and signaling strategic uncertainty.
See the full detail →
5 company-specific changes
fiscal period 2025-10-31
filed 2025-12-17
- Escalated from hypothetical trade risks to concrete, current tariff increases effective Q2 FY2025 with specific China tariff rates, retaliatory measures, and quantified financial impacts on costs and demand.
- Added specific, contemporaneous tariff escalations (Q2 FY2025 China tariffs, retaliatory measures, litigation) and quantified impact on supply chain costs, moving from hypothetical to realized risk.
See the full detail →
3 company-specific changes
fiscal period 2025-10-26
filed 2025-12-12
- New U.S. tax law (OBBBA) enacted July 2025 with detrimental impact: full valuation allowance recorded against CAMT credit deferred tax asset, increasing effective tax rate and provision in fiscal 2025. Material financial impact already realized.
- New disclosure of Chinese rare earth mineral export restrictions (2025) and potential expansion. Adds concrete, timely geopolitical supply risk beyond prior generic language.
See the full detail →
5 company-specific changes
fiscal period 2025-10-31
filed 2025-12-10
- New substantial tariffs imposed April 2025 with actual adverse impact on costs and cash flows; company unable to fully mitigate effects despite mitigation efforts.
- Material weakness in IT controls over financial reporting was disclosed last year but removed this year, indicating remediation completed. Meaningful improvement in governance risk.
See the full detail →
9 company-specific changes
fiscal period 2025-10-26
filed 2025-12-05
- New disclosure of $62M impairments already taken and $683.3M intangible assets at heightened impairment risk, including International unit with modest fair value cushion. Material forward-looking risk.
- Company disclosed $163.7M impairment charge on Garudafood investment in fiscal 2025, a concrete material loss not previously disclosed. Escalates from generic risk to realized adverse outcome.
See the full detail →
12 company-specific changes
fiscal period 2025-09-30
filed 2025-11-25
- Material new risk: proposed divestiture of Biosciences/Diagnostics business to Waters with 39.2% equity stake in combined entity. Significant transaction risk, regulatory/IRS approval uncertainty, and material costs if deal fails.
- Material M&A risk: announced separation and combination with Waters creates operational disruption, management distraction, transaction costs, and operational restrictions on a business segment.
See the full detail →
1 company-specific change
fiscal period 2025-09-30
filed 2025-11-25
- CEO Paul Reilly stepped down after 15 years; Shannon Reid's role removed from disclosure. Key leadership transition increases governance and succession risk.
See the full detail →
5 company-specific changes
fiscal period 2025-09-30
filed 2025-11-25
- Newly disclosed material cyber incident with confirmed source code exfiltration, ongoing regulatory investigations, customer/reputation harm, and substantial operational and compliance costs.
- New disclosure of a "Cyber Incident" with ongoing adverse effects on business, reputation, operations, and cash flows—a material escalation from generic security risk language.
See the full detail →
10 company-specific changes
fiscal period 2025-09-30
filed 2025-11-25
- Additional $723.9M goodwill impairment recorded; PharmaLex weakness persists and worsened, requiring full remaining goodwill write-off.
- WBA acquired by Sycamore Partners; new owners may restructure operations, accelerate store closures (1,200 stores), and seek changes to distribution agreements. Material new uncertainty regarding contract continuity and relationship stability.
See the full detail →
4 company-specific changes
fiscal period 2025-09-30
filed 2025-11-21
- Total debt decreased 24% ($1,668M to $1,270M). Senior Notes matured/were repaid; revolving borrowings increased but term loan decreased. Debt burden materially eased.
- New substantive risk disclosed: open source software licensing obligations could force disclosure of proprietary code, causing competitive harm and IP loss.
See the full detail →
2 company-specific changes
fiscal period 2025-09-30
filed 2025-11-20
- Company disclosed workforce reduction from ~23,000 to expected ~20,000 by end of fiscal 2026, with associated restructuring costs and operational risks from right-sizing actions.
- Multiple substantive additions escalate operational and execution risks: "execution difficulties" now explicitly mentioned as cause of delays; "project cancellations" added; financing default now includes "potential acceleration of cash outflows"; helium supply risk now includes upside volatility ("higher natural gas production"); technology risk now includes failure to develop AI and competitive lag; new pension risk section added. Collectively, these represent material worsening of disclosed risks.
See the full detail →
1 company-specific change
fiscal period 2025-09-30
filed 2025-11-19
- Added specific disclosure of rising insurance costs due to severe weather/natural disasters and regional coverage limitations, escalating climate-related homeownership cost risk.
See the full detail →
4 company-specific changes
fiscal period 2025-09-28
filed 2025-11-14
- New explicit disclosure of restructuring plan with significant costs and disruption risk. Prior year lacked this specificity and materiality acknowledgment.
- New disclosure of tariff risk affecting coffee procurement costs and licensee supply arrangements, escalating supply chain vulnerability beyond prior commodity price focus.
See the full detail →
4 company-specific changes
fiscal period 2025-09-30
filed 2025-11-14
- Prior year disclosed September 2023 incident vaguely; this year specifies data types impacted (employee, job applicant, personal info) and adds notification obligations, escalating disclosure and regulatory exposure.
- Added specific tariff disclosure: U.S. announced tariffs on Canada, China, EU, Japan, Mexico; reciprocal tariffs expected; explicit revenue/margin impact warning and supply chain disruption risk.
See the full detail →
10 company-specific changes
fiscal period 2025-09-27
filed 2025-11-13
- Actual YouTube TV blackout (Oct 2025) disclosed; concrete loss of distribution channel with unpredictable duration and unquantifiable impact materially worsens distribution risk.
- Removal of elevated leverage and credit rating downgrade risk indicates material improvement in debt position and financial flexibility.
See the full detail →
1 company-specific change
fiscal period 2025-09-30
filed 2025-11-12
- New disclosure of $2B+ capital investment plan with explicit risks: implementation delays, cost overruns, integration challenges, and uncertain returns. Material strategic commitment with quantified exposure.
See the full detail →
2 company-specific changes
fiscal period 2025-09-30
filed 2025-11-12
- New disclosure of U.S. Government fixed-price contract risk with cost overrun and margin pressure exposure, particularly for small-quantity or spot purchases.
- New opening language broadens risk from crashes to include product failure, misuse, and quality issues—expanding scope beyond catastrophic scenarios to operational quality risks.
See the full detail →
1 company-specific change
fiscal period 2025-09-30
filed 2025-11-10
- AspenTech acquisition completed; prior year described as "proposal" and uncertain. Now disclosed as executed transaction with integration and execution risks materialized.
See the full detail →
1 company-specific change
fiscal period 2025-09-27
filed 2025-11-10
- New World screwworm added as disease threat; HPAI language shifted from "In 2024" to present tense, suggesting ongoing/escalated concern.
See the full detail →
3 company-specific changes
fiscal period 2025-09-26
filed 2025-11-10
- Prior year disclosed ongoing BIS/DDTC investigations with $6M penalty and unquantified exposure. Current year removes all investigation details, suggesting resolution or closure of material regulatory matters.
- China exposure increased materially: manufacturing sites rose 18→19 and customer sales jumped 20%→25%, amplifying geopolitical and trade risk.
See the full detail →
19 company-specific changes
fiscal period 2025-10-03
filed 2025-11-07
- Proposed Qorvo merger introduces material risks: deal failure, regulatory uncertainty, substantial new debt, management distraction, and integration challenges. Reasonable investors would act on this.
- Material new risk: proposed $298.7M+ termination fees, regulatory/closing uncertainties, stock dilution, and significant transaction costs if Qorvo merger fails or delays.
See the full detail →
1 company-specific change
fiscal period 2025-09-30
filed 2025-11-06
- New explicit disclosure of litigation and investigation risk tied to CRS initiatives—anti-competitive, discriminatory, or unlawful allegations. Prior year lacked this specific legal exposure.
See the full detail →
6 company-specific changes
fiscal period 2025-09-28
filed 2025-11-05
- New explicit disclosure that Apple will increasingly use its own modem products rather than the company's products, with significant negative impact on QCT revenues and cash flows.
- Apple explicitly added as major customer vertically integrating; new language stating "significant negative impact" on QCT revenues and cash flows from Apple's modem transition.
See the full detail →
2 company-specific changes
fiscal period 2025-09-27
filed 2025-10-31
- New U.S. court order preventing App Store commissions on certain purchases; Google antitrust ruling and remedies threaten search licensing revenue; expanded global regulatory obligations; explicit stock price impact added.
- Removed mitigation language and added explicit consequence language. Shifted from "procedures will effectively limit" to "unable to monitor" creates heightened risk perception and potential operational/financial impact.
See the full detail →